Results 121 to 130 of about 12,135 (168)
Some of the next articles are maybe not open access.
Expert Opinion on Drug Discovery, 2007
Results from infected patients, not cured by multiple doses of praziquantel (PZQ), have been reported from different geographic locations, suggesting that resistance to the drug may be present. This has been coupled with several in vivo (e.g., studies on mice infected with 'resistant isolates') and in vitro tests (e.g., direct application and ...
Botros S
exaly +3 more sources
Results from infected patients, not cured by multiple doses of praziquantel (PZQ), have been reported from different geographic locations, suggesting that resistance to the drug may be present. This has been coupled with several in vivo (e.g., studies on mice infected with 'resistant isolates') and in vitro tests (e.g., direct application and ...
Botros S
exaly +3 more sources
Parasitology Research, 2003
Praziquantel is the drug of choice for the treatment of all forms of schistosomiasis. This review summarizes the main features of the drug, with special attention being given to those aspects that may be of interest to the practicing physician. After a brief mention of the history, the chemistry, the major available brands and their costs, doses and ...
Donato, Cioli, Livia, Pica-Mattoccia
openaire +4 more sources
Praziquantel is the drug of choice for the treatment of all forms of schistosomiasis. This review summarizes the main features of the drug, with special attention being given to those aspects that may be of interest to the practicing physician. After a brief mention of the history, the chemistry, the major available brands and their costs, doses and ...
Donato, Cioli, Livia, Pica-Mattoccia
openaire +4 more sources
Schistosomiasis and Praziquantel
Annals of Internal Medicine, 1984Excerpt To the editor: Last year, in commenting on a review article on praziquantel published in your journal (1), we reported excellent results obtained by treatingSchistosoma haematobiuminfection...
Z, Farid, B, Trabolsi, M, Stek
openaire +2 more sources
2000
Abstract Praziquantel is a pyrazinoisoquinoline derivative with anthelmintic activity for a wide variety of cestodes and trematodes. The compound, a mixture of L-and D-isomers, was Bada JL, Trevino B, Carbezos J (1988) Convulsive seizures after treatment with praziquantel. Brit Med J 296, 646. Bittencourt PRM, Gracia
openaire +1 more source
Abstract Praziquantel is a pyrazinoisoquinoline derivative with anthelmintic activity for a wide variety of cestodes and trematodes. The compound, a mixture of L-and D-isomers, was Bada JL, Trevino B, Carbezos J (1988) Convulsive seizures after treatment with praziquantel. Brit Med J 296, 646. Bittencourt PRM, Gracia
openaire +1 more source
Praziquantel and Schistosomiasis
ChemMedChem, 2010Alexander, Dömling, Kareem, Khoury
openaire +2 more sources
Praziquantel and dexamethasone
Neurology, 1988F, Alarcón, Y, Pérez, H, Banda
openaire +2 more sources
Schistosomiasis and Praziquantel
Annals of Internal Medicine, 1983Z, Farid, C K, Wallace
openaire +2 more sources